Testing effectiveness (Phase 2)Study completedNCT02307500
What this trial is testing
Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy
Who this might be right for
Pancreas CancerOvarian CancerMelanoma+4 more
Istituto Clinico Humanitas 82